Lisa Michelle Kallebo

Insider Reports History

Location
New Providence, NJ
Signature
/s/ Lisa Kallebo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Michelle Kallebo:

Company Role Class Num Shares Value Price $ Report Date Ownership
ADC Therapeutics SA Chief Accounting Officer Common Shares 128,224 $511,613 $3.99 13 Feb 2026 Direct

Insider Reports Filed by Lisa Michelle Kallebo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADCT ADC Therapeutics SA 13 Feb 2026 2 +$229,293 4 Chief Accounting Officer 18 Feb 2026, 17:44
ADCT ADC Therapeutics SA 06 Dec 2025 1 -$23,491 4 Chief Accounting Officer 09 Dec 2025, 17:09
ADCT ADC Therapeutics SA 13 Feb 2025 1 +$67,459 4 Chief Accounting Officer 14 Feb 2025, 18:22
ADCT ADC Therapeutics SA 06 Dec 2024 1 -$20,354 4 Chief Accounting Officer 09 Dec 2024, 20:39
ADCT ADC Therapeutics SA 02 Jan 2024 0 $0 3 Chief Accounting Officer 02 Jan 2024, 19:58